Suchergebnisse

The article provides an overview of programs, plans, tools of scientific and technological, innovation and industrial policy aimed at creating and producing new drugs in China; it is substantiated that the Chinese government uses an integrated approach in the implementation of mechanisms to protect and strengthen the pharmaceutical industry. It is demonstrated that the Chinese government provides business support in the form of subsidies, tax incentives, the creation of special zones for the development of high-tech industries, and helps to attract foreign direct investment in contract manufacturing and research and development, accompanied by technology transfer; through the public procurement system, a program for the development of endogenous innovations is implemented through the provision of price preferences, and advanced foreign technologies are involved. State support contributed to an increase in the level of localization of production and an increase in the number of jobs, an increase in the added value of production and the competitiveness of the pharmaceutical industry, the formation of scientific and technical competencies and the development of technologies, the creation of objects of intellectual property rights. The Chinese model of investment and innovative development, relying on the use of external technological, production, human resources, has made it possible to form a high-tech pharmaceutical sector capable of producing endogenous innovations. Given the objectives of the policy documents, Chinese enterprises are encouraged to invest in other countries in the interests of the development of Chinese pharmaceuticals.

The article provides an overview of programs, plans, tools of scientific and technological, innovation and industrial policy aimed at creating and producing new drugs in China; it is substantiated that the Chinese government uses an integrated approach in the implementation of mechanisms to protect and strengthen the pharmaceutical industry. It is demonstrated that the Chinese government provides business support in the form of subsidies, tax incentives, the creation of special zones for the development of high-tech industries, and helps to attract foreign direct investment in contract manufacturing and research and development, accompanied by technology transfer; through the public procurement system, a program for the development of endogenous innovations is implemented through the provision of price preferences, and advanced foreign technologies are involved. State support contributed to an increase in the level of localization of production and an increase in the number of jobs, an increase in the added value of production and the competitiveness of the pharmaceutical industry, the formation of scientific and technical competencies and the development of technologies, the creation of objects of intellectual property rights. The Chinese model of investment and innovative development, relying on the use of external technological, production, human resources, has made it possible to form a high-tech pharmaceutical sector capable of producing endogenous innovations. Given the objectives of the policy documents, Chinese enterprises are encouraged to invest in other countries in the interests of the development of Chinese pharmaceuticals.

1. Managing pharmaceutical projects strategically -- 2. Linking pharmaceutical projects with business strategy -- 3. Defining pharmaceutical projects -- 4. Developing pharmaceutical project strategy plans -- 5. Evaluation pharmaceutical projects -- 6. Pharmaceutical project mobilisation, control and learning -- 7. Influencing people and behaviour -- 8. Project management checklists and cost-management project case study -- 9. Conclusion.

Cover ; Contents; Part 1 Historical-Structural Dependency Analysis: Theory and Method; Part 2 A Crucial-Case Test of Dependency Theory: The Steroid Hormone Industry in Mexico; Part 3 Cross-National Dependency Analysis: The Pharmaceutical Industry in a Third World Context

Cover -- Half Title -- Title -- Copyright -- Contents -- List of Figures -- List of Tables -- Foreword -- Preface -- Acknowledgements -- About the Authors -- 1 Introduction -- What is meant by the term 'marketing plan'? -- Why marketing planning? -- How do marketing plans accommodate the future? -- The benefits of planning -- The marketing planning concept -- The marketing planning process -- The fit with company objectives, structure and planning stages -- Why a handbook of pharmaceutical marketing planning? -- Format of a marketing plan -- Information required -- 2 The External Analysis -- Establishing a customer focus -- Market segmentation -- The market analysis -- Undertaking the environmental analysis -- How to approach the environmental analysis -- Interpreting opportunity and threats -- 3 The Internal Analysis -- The search for competitive advantage -- The product audit -- The company audit -- Interpreting strengths and weaknesses -- 4 The SWOT Analysis -- What is a SWOT analysis? -- Why do you need a SWOT analysis? -- How to build a SWOT analysis -- 5 Product Strategy -- Introduction -- Definition of terms used -- Generating the strategic options -- Selecting a strategy -- 6 Sales Forecasting and Strategy -- Introduction -- Why forecasting is important -- The market forecast -- The product forecast -- Sanity checking the sales forecast -- The quarterly review -- Expenditure forecasting -- Sales forecasting methods - an overview -- 7 Strategy Implementation -- Introduction -- Critical success factors -- Setting marketing objectives -- The tactical plan -- The role of the product manager -- 8 Communications and its Role in Strategy Implementation -- The promotional mix -- Deciding on the creative strategy -- The communications process -- Integrating the other elements in the marketing mix with promotion -- The role of the external agency